About Marker Therapeutics
Investors/Media
SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Jun 8, 2023
Document Date
Mar 16, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Marker Therapeutics, Inc.
Issuer
MARKER THERAPEUTICS, INC.
Filer
Eansor Norman David